These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Tumorigenesis in neurofibromatosis type 1: role of the microenvironment. Jiang C; McKay RM; Le LQ Oncogene; 2021 Sep; 40(39):5781-5787. PubMed ID: 34345017 [TBL] [Abstract][Full Text] [Related]
50. Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts. Sherman LS; Atit R; Rosenbaum T; Cox AD; Ratner N J Biol Chem; 2000 Sep; 275(39):30740-5. PubMed ID: 10900196 [TBL] [Abstract][Full Text] [Related]
51. Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations. Serra E; Rosenbaum T; Winner U; Aledo R; Ars E; Estivill X; Lenard HG; Lázaro C Hum Mol Genet; 2000 Dec; 9(20):3055-64. PubMed ID: 11115850 [TBL] [Abstract][Full Text] [Related]
52. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene. Däschner K; Assum G; Eisenbarth I; Krone W; Hoffmeyer S; Wortmann S; Heymer B; Kehrer-Sawatzki H Biochem Biophys Res Commun; 1997 May; 234(2):346-50. PubMed ID: 9177273 [TBL] [Abstract][Full Text] [Related]
53. Developmental abnormalities and cancer predisposition in neurofibromatosis type 1. Larizza L; Gervasini C; Natacci F; Riva P Curr Mol Med; 2009 Jun; 9(5):634-53. PubMed ID: 19601812 [TBL] [Abstract][Full Text] [Related]
54. Heightened CXCR4 and CXCL12 expression in NF1-associated neurofibromas. Karaosmanoglu B; Kocaefe ÇY; Söylemezoğlu F; Anlar B; Varan A; Vargel İ; Ayter S Childs Nerv Syst; 2018 May; 34(5):877-882. PubMed ID: 29455242 [TBL] [Abstract][Full Text] [Related]
55. Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma. Plante C; Mohamad T; Hewa Bostanthirige D; Renaud M; Sidhu H; ElChoueiry M; Vatasescu JS; Poirier M; Geha S; Brosseau JP PLoS One; 2024; 19(6):e0301040. PubMed ID: 38900740 [TBL] [Abstract][Full Text] [Related]
56. Human stem cell modeling in neurofibromatosis type 1 (NF1). Wegscheid ML; Anastasaki C; Gutmann DH Exp Neurol; 2018 Jan; 299(Pt B):270-280. PubMed ID: 28392281 [TBL] [Abstract][Full Text] [Related]
57. Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development. Le LQ; Liu C; Shipman T; Chen Z; Suter U; Parada LF Cancer Res; 2011 Jul; 71(13):4686-95. PubMed ID: 21551250 [TBL] [Abstract][Full Text] [Related]
58. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Rutkowski JL; Wu K; Gutmann DH; Boyer PJ; Legius E Hum Mol Genet; 2000 Apr; 9(7):1059-66. PubMed ID: 10767330 [TBL] [Abstract][Full Text] [Related]
59. NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based model. Larribere L; Wu H; Novak D; Galach M; Bernhardt M; Orouji E; Weina K; Knappe N; Sachpekidis C; Umansky L; Beckhove P; Umansky V; De Schepper S; Kaufmann D; Ballotti R; Bertolotto C; Utikal J Pigment Cell Melanoma Res; 2015 Jul; 28(4):407-16. PubMed ID: 25824590 [TBL] [Abstract][Full Text] [Related]
60. Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I. Li K; Turner AN; Chen M; Brosius SN; Schoeb TR; Messiaen LM; Bedwell DM; Zinn KR; Anastasaki C; Gutmann DH; Korf BR; Kesterson RA Dis Model Mech; 2016 Jul; 9(7):759-67. PubMed ID: 27482814 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]